Anebulo Pharmaceuticals Inc

NASDAQ ANEB

Data sourced from iex and EODHD
Download Data

Anebulo Pharmaceuticals Inc Income Statement 2019 - 2023

This table shows the Income Statement for Anebulo Pharmaceuticals Inc going from 2019 until 2023. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Revenue
M 0 0 0 0 -
Cost of Revenue
M - - - - -
Gross Profit
M - - - - -
Operating Expenses
M - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 6 4 1 1 0
Research and Development (R&D) Expenses
M 6 3 2 2 -
Other Operating Expenses
M - - - - -
Costs and Expenses
M - - - - -
Operating Income
M -12 -7 -4 -4 0
Interest Expense
M - 0 0 0 0
Non-operating Income/Expense
M 0 0 -27 27 -
EBT
M -12 -7 -30 -30 0
Income Tax Provision
M 0 - 0 - -
Income after Tax
M -12 - -30 - -
Non-Controlling Interest
M - 0 0 8 -
Net Income
M - -12 -7 -38 -1
Shares (Basic, Weighted)
M - - - - -
Shares (Diluted, Weighted)
R 25,074,481.00 23,344,567.00 23,344,567.00 23,344,567.00 23,266,343.00
EBITDA
M -12 -7 -4 -4 -
Depreciation and Amortization
M 0 - 0 - -
EBIT
M -12 -12 -4 -4 -1
Income from Discontinued Operations
M - - - - -
Tax Rate (Effective)
% 0.89 - -0.04 - -
Earnings Per Share (EPS), Basic
M - - - - -
Earnings Per Share (EPS), Diluted
M - 0 0 0 0
Gross Profit Margin
% - - - - -
Operating Income Margin
% - - - - -
Net Income Margin
% - - - - -
EBITDA Ratio
% - - - - -
EBIT Ratio
% - - - - -
EBT Ratio
% - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email